Drug recall · September 20, 2023
WEFUN Capsules 825 mg recall
Why: Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
WEFUN Capsules 825 mg, 1x10 blister pack per carton, Manufactured by WEFUN Brooklyn NY 11204 www.eshoponlineusa.com Bar Code X00358V0O5
- Lots / codes
Lot # #18520168, Exp. date 09/30/2026 .
- Quantity
- 300 cartons
- Company
- Hua Da Trading, Inc. dba Wefun Inc., Brooklyn, NY
- Distribution
- Distributed Nationwide in the USA
- Initiated
- August 25, 2023 · Voluntary: Firm initiated
- Classified
- September 29, 2023
- Reported
- September 20, 2023
- Ended
- April 30, 2026
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.